A multicenter, open-label, single-arm, Phase IIIb trial to evaluate the effectiveness, safety, tolerability, usability and health economics resource utilization of Zalviso® for management of acute moderate to severe postoperative pain.
Phase of Trial: Phase III/IV
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Sufentanil
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Grunenthal
- 29 Nov 2017 Status changed from recruiting to completed.
- 18 Oct 2016 New trial record